Astrana Health, Inc. (NASDAQ:ASTH) Sees Significant Decline in Short Interest

Astrana Health, Inc. (NASDAQ:ASTH) saw a significant drop in short interest during the month of August. As of August 31st, there was short interest totalling 2,580,000 shares, a drop of 7.9% from the August 15th total of 2,800,000 shares. Approximately 7.1% of the shares of the company are short sold. Based on an average daily trading volume, of 223,700 shares, the days-to-cover ratio is presently 11.5 days.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the stock. Stifel Nicolaus increased their price objective on shares of Astrana Health from $48.00 to $60.00 and gave the stock a “buy” rating in a report on Thursday, August 1st. Truist Financial raised their price target on shares of Astrana Health from $50.00 to $59.00 and gave the company a “buy” rating in a research note on Friday, August 9th. Robert W. Baird boosted their price objective on Astrana Health from $54.00 to $67.00 and gave the stock an “outperform” rating in a research report on Thursday, August 15th. Finally, Baird R W raised Astrana Health to a “strong-buy” rating in a report on Thursday, May 30th. Four equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and an average price target of $59.00.

Astrana Health Trading Up 1.2 %

Shares of NASDAQ:ASTH opened at $55.11 on Tuesday. The company has a quick ratio of 1.84, a current ratio of 1.84 and a debt-to-equity ratio of 0.62. Astrana Health has a 12-month low of $28.86 and a 12-month high of $56.25. The firm has a fifty day moving average of $48.54 and a two-hundred day moving average of $43.10. The firm has a market capitalization of $3.09 billion, a P/E ratio of 41.75, a price-to-earnings-growth ratio of 1.85 and a beta of 1.20.

Astrana Health (NASDAQ:ASTH) last announced its quarterly earnings results on Wednesday, August 7th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.39 by $0.01. The business had revenue of $486.30 million during the quarter, compared to analysts’ expectations of $440.68 million. Astrana Health had a return on equity of 10.71% and a net margin of 4.30%. The firm’s quarterly revenue was up 39.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.28 EPS. On average, equities analysts expect that Astrana Health will post 1.33 EPS for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.